Chimerix Inc (CMRX)
0.9924
-0.05
(-4.58%)
USD |
NASDAQ |
Nov 12, 16:00
0.9889
0.00 (0.00%)
After-Hours: 20:00
Chimerix Net Income (TTM): -84.70M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -84.70M |
| March 31, 2024 | -82.59M |
| December 31, 2023 | -82.10M |
| September 30, 2023 | -84.89M |
| June 30, 2023 | 180.45M |
| March 31, 2023 | 175.56M |
| December 31, 2022 | 172.17M |
| September 30, 2022 | 153.63M |
| June 30, 2022 | -106.29M |
| March 31, 2022 | -100.59M |
| December 31, 2021 | -173.24M |
| September 30, 2021 | -145.41M |
| June 30, 2021 | -138.26M |
| March 31, 2021 | -130.52M |
| December 31, 2020 | -43.52M |
| September 30, 2020 | -35.35M |
| June 30, 2020 | -97.67M |
| March 31, 2020 | -105.30M |
| December 31, 2019 | -112.58M |
| September 30, 2019 | -124.03M |
| June 30, 2019 | -66.38M |
| March 31, 2019 | -67.34M |
| December 31, 2018 | -69.47M |
| September 30, 2018 | -73.76M |
| Date | Value |
|---|---|
| June 30, 2018 | -74.99M |
| March 31, 2018 | -73.06M |
| December 31, 2017 | -70.98M |
| September 30, 2017 | -66.70M |
| June 30, 2017 | -66.42M |
| March 31, 2017 | -67.88M |
| December 31, 2016 | -76.39M |
| September 30, 2016 | -99.28M |
| June 30, 2016 | -114.70M |
| March 31, 2016 | -121.37M |
| December 31, 2015 | -117.37M |
| September 30, 2015 | -99.78M |
| June 30, 2015 | -84.28M |
| March 31, 2015 | -71.20M |
| December 31, 2014 | -59.31M |
| September 30, 2014 | -47.24M |
| June 30, 2014 | -36.99M |
| March 31, 2014 | -37.72M |
| December 31, 2013 | -36.44M |
| September 30, 2013 | -32.60M |
| June 30, 2013 | -14.75M |
| March 31, 2013 | -6.615M |
| December 31, 2012 | -4.406M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-173.24M
Minimum
Dec 2021
180.45M
Maximum
Jun 2023
-44.27M
Average
-84.89M
Median
Sep 2023
Net Income (TTM) Benchmarks
| Abbott Laboratories | 5.767B |
| Emergent BioSolutions Inc | -587.00M |
| SIGA Technologies Inc | 83.97M |
| Tonix Pharmaceuticals Holding Corp | -149.01M |
| Geovax Labs Inc | -26.92M |